SHOC2 and cancer: Furthermore, many gain- and loss-of-function approaches found that loss-of-function of SHOC2 was related to impaired cell motility and delays cell attachment, while gain-of-function of SHOC2 was associated with oncogenic ERK signaling in cancer (Silveira et al., 2020).